{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:42:23Z","timestamp":1791384143755,"version":"4.3.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Key Project of Natural Science Foundation of Tianjin Province","award":["12JCZDJC24200"],"award-info":[{"award-number":["12JCZDJC24200"]}]},{"name":"the Program for New Century Excellent Talents in University of China","award":["NCET 111067"],"award-info":[{"award-number":["NCET 111067"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81322018"],"award-info":[{"award-number":["81322018"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81100887"],"award-info":[{"award-number":["81100887"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81273287"],"award-info":[{"award-number":["81273287"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12974-016-0559-x","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T16:56:49Z","timestamp":1462294609000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Dimethyl fumarate attenuates experimental autoimmune neuritis through the nuclear factor erythroid-derived 2-related factor 2\/hemoxygenase-1 pathway by altering the balance of M1\/M2 macrophages"],"prefix":"10.1186","volume":"13","author":[{"given":"Ranran","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinting","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,3]]},"reference":[{"key":"559_CR1","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP. Guillain-Barre syndrome. N Engl J Med. 2012;366:2294\u2013304.","journal-title":"N Engl J Med"},{"key":"559_CR2","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1093\/brain\/awm004","volume":"130","author":"RA Hughes","year":"2007","unstructured":"Hughes RA, Swan AV, Raphael JC, Annane D, van Koningsveld R, van Doorn PA. Immunotherapy for Guillain-Barre syndrome: a systematic review. Brain. 2007;130:2245\u201357.","journal-title":"Brain"},{"key":"559_CR3","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","volume":"366","author":"RA Hughes","year":"2005","unstructured":"Hughes RA, Cornblath DR. Guillain-Barre syndrome. Lancet. 2005;366:1653\u201366.","journal-title":"Lancet"},{"key":"559_CR4","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","volume":"24","author":"HL Zhang","year":"2013","unstructured":"Zhang HL, Zheng XY, Zhu J. Th1\/Th2\/Th17\/Treg cytokines in Guillain-Barre syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev. 2013;24:443\u201353.","journal-title":"Cytokine Growth Factor Rev"},{"key":"559_CR5","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0165-5728(97)00238-5","volume":"84","author":"J Zhu","year":"1998","unstructured":"Zhu J, Mix E, Link H. Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barre syndrome. J Neuroimmunol. 1998;84:40\u201352.","journal-title":"J Neuroimmunol"},{"key":"559_CR6","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","volume":"122","author":"A Sica","year":"2012","unstructured":"Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas. J Clin Invest. 2012;122:787\u201395.","journal-title":"J Clin Invest"},{"key":"559_CR7","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","volume":"11","author":"SK Biswas","year":"2010","unstructured":"Biswas SK, Mantovani A. Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm. Nat Immunol. 2010;11:889\u201396.","journal-title":"Nat Immunol"},{"key":"559_CR8","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol. 2008;8:958\u201369.","journal-title":"Nat Rev Immunol"},{"issue":"Pt 5","key":"559_CR9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/brain\/111.5.1039","volume":"111","author":"HP Hartung","year":"1988","unstructured":"Hartung HP, Schafer B, Heininger K, Stoll G, Toyka KV. The role of macrophages and eicosanoids in the pathogenesis of experimental allergic neuritis. Serial clinical, electrophysiological, biochemical and morphological observations. Brain. 1988;111(Pt 5):1039\u201359.","journal-title":"Brain"},{"key":"559_CR10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/path.4133","volume":"229","author":"A Mantovani","year":"2013","unstructured":"Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M. Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol. 2013;229:176\u201385.","journal-title":"J Pathol"},{"key":"559_CR11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0301-0082(00)00060-5","volume":"64","author":"R Kiefer","year":"2001","unstructured":"Kiefer R, Kieseier BC, Stoll G, Hartung HP. The role of macrophages in immune-mediated damage to the peripheral nervous system. Prog Neurobiol. 2001;64:109\u201327.","journal-title":"Prog Neurobiol"},{"key":"559_CR12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature12034","volume":"496","author":"TA Wynn","year":"2013","unstructured":"Wynn TA, Chawla A, Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013;496:445\u201355.","journal-title":"Nature"},{"key":"559_CR13","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1517\/13543784.2010.534778","volume":"19","author":"A Papadopoulou","year":"2010","unstructured":"Papadopoulou A, D'Souza M, Kappos L, Yaldizli O. Dimethyl fumarate for multiple sclerosis. Expert Opin Investig Drugs. 2010;19:1603\u201312.","journal-title":"Expert Opin Investig Drugs"},{"key":"559_CR14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1586\/14737175.2013.814958","volume":"13","author":"DH Lee","year":"2013","unstructured":"Lee DH, Stangel M, Gold R, Linker RA. The fumaric acid ester BG-12: a new option in MS therapy. Expert Rev Neurother. 2013;13:951\u20138.","journal-title":"Expert Rev Neurother"},{"key":"559_CR15","doi-asserted-by":"crossref","first-page":"e0143416","DOI":"10.1371\/journal.pone.0143416","volume":"10","author":"K Pitarokoili","year":"2015","unstructured":"Pitarokoili K, Ambrosius B, Meyer D, Schrewe L, Gold R. Dimethyl fumarate ameliorates Lewis rat experimental autoimmune neuritis and mediates axonal protection. PLoS One. 2015;10:e0143416.","journal-title":"PLoS One"},{"key":"559_CR16","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(08)61619-0","volume":"372","author":"L Kappos","year":"2008","unstructured":"Kappos L, Gold R, Miller DH, Macmanus DG, Havrdova E, Limmroth V, Polman CH, Schmierer K, Yousry TA, Yang M, et al. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study. Lancet. 2008;372:1463\u201372.","journal-title":"Lancet"},{"key":"559_CR17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1056\/NEJMoa1206328","volume":"367","author":"RJ Fox","year":"2012","unstructured":"Fox RJ, Miller DH, Phillips JT, Hutchinson M, Havrdova E, Kita M, Yang M, Raghupathi K, Novas M, Sweetser MT, et al. Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis. N Engl J Med. 2012;367:1087\u201397.","journal-title":"N Engl J Med"},{"key":"559_CR18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1756285614564152","volume":"8","author":"R Bomprezzi","year":"2015","unstructured":"Bomprezzi R. Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview. Ther Adv Neurol Disord. 2015;8:20\u201330.","journal-title":"Ther Adv Neurol Disord"},{"key":"559_CR19","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1093\/brain\/awq386","volume":"134","author":"RA Linker","year":"2011","unstructured":"Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S, et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain. 2011;134:678\u201392.","journal-title":"Brain"},{"key":"559_CR20","doi-asserted-by":"crossref","first-page":"7266","DOI":"10.3390\/molecules15107266","volume":"15","author":"KA Jung","year":"2010","unstructured":"Jung KA, Kwak MK. The Nrf2 system as a potential target for the development of indirect antioxidants. Molecules. 2010;15:7266\u201391.","journal-title":"Molecules"},{"key":"559_CR21","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.bcp.2010.07.014","volume":"80","author":"A Paine","year":"2010","unstructured":"Paine A, Eiz-Vesper B, Blasczyk R, Immenschuh S. Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential. Biochem Pharmacol. 2010;80:1895\u2013903.","journal-title":"Biochem Pharmacol"},{"key":"559_CR22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.abb.2014.09.005","volume":"564","author":"Y Naito","year":"2014","unstructured":"Naito Y, Takagi T, Higashimura Y. Heme oxygenase-1 and anti-inflammatory M2 macrophages. Arch Biochem Biophys. 2014;564:83\u20138.","journal-title":"Arch Biochem Biophys"},{"key":"559_CR23","doi-asserted-by":"crossref","first-page":"e107111","DOI":"10.1371\/journal.pone.0107111","volume":"9","author":"L Robles","year":"2014","unstructured":"Robles L, Vaziri ND, Li S, Masuda Y, Takasu C, Takasu M, Vo K, Farzaneh SH, Stamos MJ, Ichii H. Dimethyl fumarate protects pancreatic islet cells and non-endocrine tissue in L-arginine-induced chronic pancreatitis. PLoS One. 2014;9:e107111.","journal-title":"PLoS One"},{"key":"559_CR24","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/MPA.0000000000000275","volume":"44","author":"L Robles","year":"2015","unstructured":"Robles L, Vaziri ND, Li S, Takasu C, Masuda Y, Vo K, Farzaneh SH, Stamos MJ, Ichii H. Dimethyl fumarate ameliorates acute pancreatitis in rodent. Pancreas. 2015;44:441\u20137.","journal-title":"Pancreas"},{"key":"559_CR25","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1471-4159.2006.04309.x","volume":"100","author":"JP Sarkey","year":"2007","unstructured":"Sarkey JP, Richards MP, Stubbs Jr EB. Lovastatin attenuates nerve injury in an animal model of Guillain-Barre syndrome. J Neurochem. 2007;100:1265\u201377.","journal-title":"J Neurochem"},{"key":"559_CR26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuroscience.2014.01.004","volume":"262","author":"J Xiao","year":"2014","unstructured":"Xiao J, Zhai H, Yao Y, Wang C, Jiang W, Zhang C, Simard AR, Zhang R, Hao J. Chrysin attenuates experimental autoimmune neuritis by suppressing immuno-inflammatory responses. Neuroscience. 2014;262:156\u201364.","journal-title":"Neuroscience"},{"key":"559_CR27","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/icb.2013.81","volume":"92","author":"CJ Zhang","year":"2014","unstructured":"Zhang CJ, Zhai H, Yan Y, Hao J, Li MS, Jin WN, Su N, Vollmer TL, Shi FD. Glatiramer acetate ameliorates experimental autoimmune neuritis. Immunol Cell Biol. 2014;92:164\u20139.","journal-title":"Immunol Cell Biol"},{"key":"559_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/nri978","volume":"3","author":"S Gordon","year":"2003","unstructured":"Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23\u201335.","journal-title":"Nat Rev Immunol"},{"key":"559_CR29","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.4049\/jimmunol.0901088","volume":"183","author":"Z Zhang","year":"2009","unstructured":"Zhang Z, Zhang ZY, Schluesener HJ. Compound A, a plant origin ligand of glucocorticoid receptors, increases regulatory T cells and M2 macrophages to attenuate experimental autoimmune neuritis with reduced side effects. J Immunol. 2009;183:3081\u201391.","journal-title":"J Immunol"},{"key":"559_CR30","doi-asserted-by":"crossref","first-page":"e38157","DOI":"10.1371\/journal.pone.0038157","volume":"7","author":"HL Zhang","year":"2012","unstructured":"Zhang HL, Hassan MY, Zheng XY, Azimullah S, Quezada HC, Amir N, Elwasila M, Mix E, Adem A, Zhu J. Attenuated EAN in TNF-alpha deficient mice is associated with an altered balance of M1\/M2 macrophages. PLoS One. 2012;7:e38157.","journal-title":"PLoS One"},{"key":"559_CR31","doi-asserted-by":"crossref","first-page":"680","DOI":"10.4049\/jimmunol.181.1.680","volume":"181","author":"NG Innamorato","year":"2008","unstructured":"Innamorato NG, Rojo AI, Garcia-Yague AJ, Yamamoto M, de Ceballos ML, Cuadrado A. The transcription factor Nrf2 is a therapeutic target against brain inflammation. J Immunol. 2008;181:680\u20139.","journal-title":"J Immunol"},{"key":"559_CR32","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1161\/STROKEAHA.107.486506","volume":"38","author":"X Zhao","year":"2007","unstructured":"Zhao X, Sun G, Zhang J, Strong R, Dash PK, Kan YW, Grotta JC, Aronowski J. Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke. 2007;38:3280\u20136.","journal-title":"Stroke"},{"key":"559_CR33","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1161\/STROKEAHA.115.009398","volume":"46","author":"X Zhao","year":"2015","unstructured":"Zhao X, Sun G, Zhang J, Ting SM, Gonzales N, Aronowski J. Dimethyl fumarate protects brain from damage produced by intracerebral hemorrhage by mechanism involving Nrf2. Stroke. 2015;46:1923\u20138.","journal-title":"Stroke"},{"key":"559_CR34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5483\/BMBRep.2004.37.2.139","volume":"37","author":"JM Lee","year":"2004","unstructured":"Lee JM, Johnson JA. An important role of Nrf2-ARE pathway in the cellular defense mechanism. J Biochem Mol Biol. 2004;37:139\u201343.","journal-title":"J Biochem Mol Biol"},{"key":"559_CR35","doi-asserted-by":"crossref","first-page":"11783","DOI":"10.3390\/ijms130911783","volume":"13","author":"DH Lee","year":"2012","unstructured":"Lee DH, Gold R, Linker RA. Mechanisms of oxidative damage in multiple sclerosis and neurodegenerative diseases: therapeutic modulation via fumaric acid esters. Int J Mol Sci. 2012;13:11783\u2013803.","journal-title":"Int J Mol Sci"},{"key":"559_CR36","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.cytogfr.2014.09.002","volume":"26","author":"Y Yang","year":"2015","unstructured":"Yang Y, Jiang S, Yan J, Li Y, Xin Z, Lin Y, Qu Y. An overview of the molecular mechanisms and novel roles of Nrf2 in neurodegenerative disorders. Cytokine Growth Factor Rev. 2015;26:47\u201357.","journal-title":"Cytokine Growth Factor Rev"},{"key":"559_CR37","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1152\/physrev.00011.2005","volume":"86","author":"SW Ryter","year":"2006","unstructured":"Ryter SW, Alam J, Choi AM. Heme oxygenase-1\/carbon monoxide: from basic science to therapeutic applications. Physiol Rev. 2006;86:583\u2013650.","journal-title":"Physiol Rev"},{"key":"559_CR38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1165\/rcmb.2009-0170TR","volume":"41","author":"SW Ryter","year":"2009","unstructured":"Ryter SW, Choi AM. Heme oxygenase-1\/carbon monoxide: from metabolism to molecular therapy. Am J Respir Cell Mol Biol. 2009;41:251\u201360.","journal-title":"Am J Respir Cell Mol Biol"},{"key":"559_CR39","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S0165-5728(00)00352-0","volume":"110","author":"HJ Schluesener","year":"2000","unstructured":"Schluesener HJ, Seid K. Heme oxygenase-1 in lesions of rat experimental autoimmune encephalomyelitis and neuritis. J Neuroimmunol. 2000;110:114\u201320.","journal-title":"J Neuroimmunol"},{"key":"559_CR40","doi-asserted-by":"crossref","first-page":"13460","DOI":"10.1074\/jbc.M110.204644","volume":"286","author":"P Mandal","year":"2011","unstructured":"Mandal P, Pratt BT, Barnes M, McMullen MR, Nagy LE. Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin. J Biol Chem. 2011;286:13460\u20139.","journal-title":"J Biol Chem"},{"key":"559_CR41","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1084\/jem.20100977","volume":"208","author":"K Ghoreschi","year":"2011","unstructured":"Ghoreschi K, Bruck J, Kellerer C, Deng C, Peng H, Rothfuss O, Hussain RZ, Gocke AR, Respa A, Glocova I, et al. Fumarates improve psoriasis and multiple sclerosis by inducing type II dendritic cells. J Exp Med. 2011;208:2291\u2013303.","journal-title":"J Exp Med"},{"key":"559_CR42","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2249.2006.03094.x","volume":"145","author":"S Schilling","year":"2006","unstructured":"Schilling S, Goelz S, Linker R, Luehder F, Gold R. Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. Clin Exp Immunol. 2006;145:101\u20137.","journal-title":"Clin Exp Immunol"},{"key":"559_CR43","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1172\/JCI72151","volume":"124","author":"H Chen","year":"2014","unstructured":"Chen H, Assmann JC, Krenz A, Rahman M, Grimm M, Karsten CM, Kohl J, Offermanns S, Wettschureck N, Schwaninger M. Hydroxycarboxylic acid receptor 2 mediates dimethyl fumarate\u2019s protective effect in EAE. J Clin Invest. 2014;124:2188\u201392.","journal-title":"J Clin Invest"},{"key":"559_CR44","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.arcmed.2008.07.003","volume":"39","author":"M Milenkovic","year":"2008","unstructured":"Milenkovic M, Arsenovic-Ranin N, Vucicevic D, Bufan B, Jancic I, Stojic-Vukanic Z. Beneficial effects of dimethyl fumarate on experimental autoimmune myocarditis. Arch Med Res. 2008;39:639\u201346.","journal-title":"Arch Med Res"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-016-0559-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T18:16:59Z","timestamp":1655662619000},"score":1,"resource":{"primary":{"URL":"http:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-016-0559-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,3]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["559"],"URL":"https:\/\/doi.org\/10.1186\/s12974-016-0559-x","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,3]]},"article-number":"97"}}